These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 11912140

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M, Haas R, Brauch H, Acker T, Flamme I, Plate KH.
    Oncogene; 2000 Nov 16; 19(48):5435-43. PubMed ID: 11114720
    [Abstract] [Full Text] [Related]

  • 4. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas.
    Wiesener MS, Münchenhagen PM, Berger I, Morgan NV, Roigas J, Schwiertz A, Jürgensen JS, Gruber G, Maxwell PH, Löning SA, Frei U, Maher ER, Gröne HJ, Eckardt KU.
    Cancer Res; 2001 Jul 01; 61(13):5215-22. PubMed ID: 11431362
    [Abstract] [Full Text] [Related]

  • 5. Regulation of tyrosine hydroxylase promoter activity by the von Hippel-Lindau tumor suppressor protein and hypoxia-inducible transcription factors.
    Schnell PO, Ignacak ML, Bauer AL, Striet JB, Paulding WR, Czyzyk-Krzeska MF.
    J Neurochem; 2003 Apr 01; 85(2):483-91. PubMed ID: 12675925
    [Abstract] [Full Text] [Related]

  • 6. Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein.
    Siemeister G, Weindel K, Mohrs K, Barleon B, Martiny-Baron G, Marmé D.
    Cancer Res; 1996 May 15; 56(10):2299-301. PubMed ID: 8625303
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
    Blancher C, Moore JW, Robertson N, Harris AL.
    Cancer Res; 2001 Oct 01; 61(19):7349-55. PubMed ID: 11585776
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Coexpression of erythropoietin and vascular endothelial growth factor in nervous system tumors associated with von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M, Marti HH, Plate KH.
    Blood; 1998 Nov 01; 92(9):3388-93. PubMed ID: 9787178
    [Abstract] [Full Text] [Related]

  • 12. Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: regulation by the von Hippel-Lindau gene and hypoxia.
    Gunningham SP, Currie MJ, Han C, Turner K, Scott PA, Robinson BA, Harris AL, Fox SB.
    Cancer Res; 2001 Apr 01; 61(7):3206-11. PubMed ID: 11306510
    [Abstract] [Full Text] [Related]

  • 13. Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene.
    Gnarra JR, Zhou S, Merrill MJ, Wagner JR, Krumm A, Papavassiliou E, Oldfield EH, Klausner RD, Linehan WM.
    Proc Natl Acad Sci U S A; 1996 Oct 01; 93(20):10589-94. PubMed ID: 8855222
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Alternate choice of initiation codon produces a biologically active product of the von Hippel Lindau gene with tumor suppressor activity.
    Blankenship C, Naglich JG, Whaley JM, Seizinger B, Kley N.
    Oncogene; 1999 Feb 25; 18(8):1529-35. PubMed ID: 10102622
    [Abstract] [Full Text] [Related]

  • 16. von Hippel Lindau tumor suppressor and HIF-1alpha: new targets of NSAIDs inhibition of hypoxia-induced angiogenesis.
    Jones MK, Szabó IL, Kawanaka H, Husain SS, Tarnawski AS.
    FASEB J; 2002 Feb 25; 16(2):264-6. PubMed ID: 11772947
    [Abstract] [Full Text] [Related]

  • 17. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.
    Iliopoulos O, Levy AP, Jiang C, Kaelin WG, Goldberg MA.
    Proc Natl Acad Sci U S A; 1996 Oct 01; 93(20):10595-9. PubMed ID: 8855223
    [Abstract] [Full Text] [Related]

  • 18. Hypoxia-inducible protein binding to vascular endothelial growth factor mRNA and its modulation by the von Hippel-Lindau protein.
    Levy AP, Levy NS, Goldberg MA.
    J Biol Chem; 1996 Oct 11; 271(41):25492-7. PubMed ID: 8810320
    [Abstract] [Full Text] [Related]

  • 19. von Hippel-Lindau tumor suppressor protein represses platelet-derived growth factor B-chain gene expression via the Sp1 binding element in the proximal PDGF-B promoter.
    Rafty LA, Khachigian LM.
    J Cell Biochem; 2002 Oct 11; 85(3):490-5. PubMed ID: 11967988
    [Abstract] [Full Text] [Related]

  • 20. Vascular endothelial growth factor overexpression is correlated with von Hippel-Lindau tumor suppressor gene inactivation in patients with sporadic renal cell carcinoma.
    Igarashi H, Esumi M, Ishida H, Okada K.
    Cancer; 2002 Jul 01; 95(1):47-53. PubMed ID: 12115316
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.